About: Benefits of complementary therapy with insulin aspart versus human regular insulin in persons with type 2 diabetes mellitus     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
Description
  • Absorption rates of the phosphate-buffered insulin analogs aspart, lispro, and glulisine prevail over that of regular human insulin. The aim of this prospective observational open-label controlled study was to compare the effects of aspart and human regular insulin resulting from their sequential long-lasting routine administration in small preprandial boluses to individuals with type 2 diabetes acccording to identical algorithms
  • Absorption rates of the phosphate-buffered insulin analogs aspart, lispro, and glulisine prevail over that of regular human insulin. The aim of this prospective observational open-label controlled study was to compare the effects of aspart and human regular insulin resulting from their sequential long-lasting routine administration in small preprandial boluses to individuals with type 2 diabetes acccording to identical algorithms (en)
  • Cíl: Cílem této prospektivní observační otevřené studie bylo porovnat účinky inzulínem Aspart s účinky krátkodobého humánního inzulínu při dlouhodobém podávání v malých prepondiálních dávkách osobám s diabetem 2. typu na základě stejných algoritmů. Metoda: Bylo vyšetřeno 57 osob s DM 2. typu (cs)
Title
  • Benefits of complementary therapy with insulin aspart versus human regular insulin in persons with type 2 diabetes mellitus
  • Benefits of complementary therapy with insulin aspart versus human regular insulin in persons with type 2 diabetes mellitus (en)
  • Výhody komplementární léčby inzulin aspartátem versus normálním lidským inzulinem u nemocných s diabetem II. typu (cs)
skos:prefLabel
  • Benefits of complementary therapy with insulin aspart versus human regular insulin in persons with type 2 diabetes mellitus
  • Benefits of complementary therapy with insulin aspart versus human regular insulin in persons with type 2 diabetes mellitus (en)
  • Výhody komplementární léčby inzulin aspartátem versus normálním lidským inzulinem u nemocných s diabetem II. typu (cs)
skos:notation
  • RIV/00216208:11120/07:00001307!RIV09-MZ0-11120___
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • P(NR7825), Z(MZ00000064211)
http://linked.open...iv/cisloPeriodika
  • 3
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 411535
http://linked.open...ai/riv/idVysledku
  • RIV/00216208:11120/07:00001307
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • insulin Aspart; complementary insulin therapy; type 2 diabetes mellitus (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • US - Spojené státy americké
http://linked.open...ontrolniKodProRIV
  • [93C097BF2967]
http://linked.open...i/riv/nazevZdroje
  • Diabetes Technology & Therapeutics
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...vavai/riv/projekt
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 9
http://linked.open...iv/tvurceVysledku
  • Zatloukal, Petr
  • Zapletalová, J.
  • Doubravová, B.
  • Chlupová, L.
  • Malá, E.
  • Pukowietz, L.
  • Chlup, R.
  • Seckar, P.
  • Tancošová, S.
http://linked.open...ain/vavai/riv/wos
  • 000247337800003
http://linked.open...n/vavai/riv/zamer
issn
  • 1520-9156
number of pages
http://localhost/t...ganizacniJednotka
  • 11120
is http://linked.open...avai/riv/vysledek of
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 114 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software